SORBA, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 1.394
NA - Nord America 1.263
AS - Asia 360
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 2
Totale 3.025
Nazione #
US - Stati Uniti d'America 1.254
IE - Irlanda 405
DE - Germania 229
SE - Svezia 221
IT - Italia 191
UA - Ucraina 154
CN - Cina 121
FI - Finlandia 105
SG - Singapore 72
IN - India 61
HK - Hong Kong 52
TR - Turchia 32
CZ - Repubblica Ceca 27
GB - Regno Unito 26
BE - Belgio 14
IR - Iran 13
RU - Federazione Russa 10
CA - Canada 9
EU - Europa 6
VN - Vietnam 6
FR - Francia 3
GR - Grecia 3
LT - Lituania 3
CH - Svizzera 1
CL - Cile 1
IQ - Iraq 1
KR - Corea 1
LV - Lettonia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
Totale 3.025
Città #
Dublin 405
Jacksonville 296
Dearborn 156
Ann Arbor 106
Chandler 87
Piemonte 76
Wilmington 76
Hong Kong 52
Singapore 52
Lawrence 51
Princeton 51
Beijing 49
San Mateo 49
Andover 35
Brno 27
Ashburn 25
Bremen 20
Ankara 17
Helsinki 16
Brussels 14
Munich 10
Hefei 9
Kunming 9
Milan 9
Nanjing 9
Kocaeli 8
Norwalk 8
Santa Clara 8
Toronto 8
Woodbridge 8
Grignasco 7
Kecioeren 7
Nanchang 7
Dong Ket 6
Formigine 6
Monmouth Junction 6
Novara 6
Jinan 5
Noicattaro 5
Torino 5
Turin 5
Berlin 4
Boardman 4
Chengdu 4
Fairfield 4
Houston 4
London 4
Shenyang 4
Zanjan 4
Ardabil 3
Athens 3
Düsseldorf 3
Frankfurt am Main 3
Hebei 3
Ipswich 3
Leawood 3
Xian 3
Augusta 2
Cambridge 2
Cassano Magnago 2
Cerano 2
Espoo 2
Falkenstein 2
Gunzenhausen 2
Montesarchio 2
Occimiano 2
Pavia 2
Philadelphia 2
Redmond 2
St Petersburg 2
Wachtberg 2
Absecon 1
Albano Laziale 1
Baghdad 1
Bangalore 1
Baotou 1
Borgomanero 1
Changchun 1
Changsha 1
Chelyabinsk 1
Como 1
Des Moines 1
Fuzhou 1
Gravedona 1
Guangzhou 1
Henderson 1
Imola 1
Jincheng 1
Kaunas 1
Kurgan 1
La Canada Flintridge 1
Las Vegas 1
Lima 1
Malakoff 1
Manila 1
Nanning 1
Nanping 1
Novokuznetsk 1
Ottawa 1
Quzhou 1
Totale 1.924
Nome #
Inhibitors of Nicotinamide Phosphoribosyltransferase, compositions, products and uses thereof. 106
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 101
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 98
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 90
Capitolo 23. Istamina e agenti antistaminici 88
A Concise Synthesis of Pyrazole Analogues of Combretastatin A1 as Potent Antitubulin Agents 84
Identification of a Potent Phosphoinositide 3-Kinase Pan Inhibitor Displaying a Strategic Carboxylic Acid Group and Development of Its Prodrugs 82
Synthesis and pharmacological characterization of new H2-antagonists containing NO-donor moieties, endowed with mixed antisecretory and gastroprotective activities 79
In silico-driven multicomponent synthesis of 4,5- and 1,5-disubstituted imidazoles as indoleamine 2,3-dioxygenase inhibitors 79
The Guareschi Pyridine Scaffold as a Valuable Platform for the Identification of Selective PI3K Inhibitors 79
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 78
Anti-Helicobacter pylori agents endowed with H2-antagonist properties 77
Are 1,4- and 1,5-Disubstituted 1,2,3-Triazoles Good Pharmacophoric Groups? 76
A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies 76
Quinolin-4 (1h) -one derivatives as inhibitors of phosphatidylinositol 3-kinases 72
Groebke multicomponent reaction and subsequent nucleophilic aromatic substitution for a convenient synthesis of 3,8-diaminoimidazo[1,2-a]pyrazines as potential kinase inhibitors 72
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 71
Estrogenic analogues synthesized by click chemistry 68
Replacement of the double bond of antitubulin chalcones with triazoles and tetrazoles: synthesis and biological evaluation 66
Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2 64
Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage 61
Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry 61
Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes 60
Design, synthesis, and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase 60
Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus 60
Solution-phase parallel synthesis and biological evaluation of combretatriazoles 56
A new furoxan NO-donor rabeprazole derivative and related compounds 56
Triazole-modified histone deacetylase inhibitors as a rapid route to drug discovery 55
Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents 55
Essential role of the p110β subunit of phosphoinositide 3-OH kinase in male fertility 54
ZINClick: A Database of 16 Million Novel, Patentable, and Readily Synthesizable 1,4-Disubstituted Triazoles 53
A practical synthesis of 5-aroyl-1-aryltetrazoles using an Ugi-like 4-component reaction followed by a biomimetic transamination 52
Synthesis and cytotoxic evaluation of combretafurazans 51
“Identification of the first selective Sirt3 inhibitor”, 51
De novo computer-aided design of novel antiviral agents 50
[3-(1H-Imidazol-4-yl)propyl]guanidines containing furoxan moieties: a New Class of H3-Antagonists endowed with NO-Donor properties 49
“Synthesis and in vitro evaluation of tetrasubstituted pyridines as potential PI3Ks inhibitors” 48
Synthesis, biological evaluation, and molecular docking of Ugi products containing a zinc-chelating moiety as novel inhibitors of histone deacetylase 47
Furoxan Analogues of the Histamine H3 receptor antagonist imoproxifan and related furazan derivatives 46
Medicinal chemistry of combretastatin A4: present and future directions 44
Molecular Field Analysis and 3D-Quantitative Structure-Activity Relationship Studies (MFA 3D-QSAR) of Bile Acids and Fexaramine Derivatives as Agonists of Farnesoid X Receptor (FXR) 44
Synthesis and anti-Helicobacter pylori properties of NO-donor/metronidazole hybrids and related compounds 43
The tubulin colchicine domain: a molecular modelling perspective 43
In search of novel antitubulin agents: synthesis of 1-aryl-5-aroyl tetrazoles by an Ugi 4-CR/hydrogenolysis/transamination reaction 42
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 39
Synthesis and biological evaluation of combretatriazoles 39
Role of the nicotinic acid group in NAADP receptor selectivity 38
Rapid synthesis of triazole-modified resveratrol analogues via click chemistry 36
NO-donors: focus on furoxan derivatives 36
Icilio Guareschi and his amazing “1897 reaction” 36
Unsymmetrically substituted furoxans. Part 18. Smiles rearrangement in furoxan systems and in related furazans 35
Totale 3.106
Categoria #
all - tutte 16.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.435


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020478 0 0 0 0 0 93 143 34 58 83 67 0
2020/2021399 57 3 52 8 51 30 53 5 56 25 53 6
2021/2022376 23 6 44 48 19 1 40 8 20 22 50 95
2022/2023869 59 40 64 17 60 87 29 51 416 3 23 20
2023/2024230 22 16 23 13 45 0 54 4 1 0 17 35
2024/2025111 15 16 37 5 26 12 0 0 0 0 0 0
Totale 3.106